Rockville, Nov. 02, 2022 (GLOBE NEWSWIRE) -- At present, the global patient blood management market is valued at US$ 12.7 billion and is projected to expand at a high-value CAGR of 7.7% through 2027, as per the latest study by Fact.MR.
The world has witnessed a prominent increase in the incidence of blood disorders and this has led to the high demand for plasma and blood transfusions across the world, which is expected to favor the patient blood management market growth potential in the future. However, the market is expected to be faced with challenges such as the illegal stocking of blood, corruption in blood banks, and high costs of automated patient blood management systems.
Download Sample Copy of This Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=7783
Key Takeaways from Market Study
- The global patient blood management market in 2022 is valued at US$ 12.7 billion.
- Over the next five years, the market is expected to exhibit expansion at a CAGR of 7.7%.
- By 2027, the market for patient blood management is anticipated to account for a valuation of US$ 18.4 billion.
- Rising prevalence of blood disorders, increasing number of blood donors, growing awareness of blood transfusion in developing countries, supportive government initiatives, and technological advancements are projected to drive market growth.
- Demand for patient blood management in China is anticipated to increase at a stellar CAGR of 10% and reach US$ 3.8 billion by the end of 2027.
- However, the high costs of patient blood management devices are slated to dent market progress to some extent.
- The United States market enjoys a valuation of US$ 3.5 billion in 2022.
- Demand for software is projected to rise at 6.3% CAGR across the forecast period.
Key Companies Profiled
- Macopharma
- Biomérieux SA
- F. Hoffmann-La Roche LTD.
- Terumo Corporation
- Asahi Kasei Medical Co. Ltd.
- Immucor Inc.
- Kaneka Corporation
- Abbott Laboratories
- Grifols S.A.
- Bio-Rad Laboratories Inc.
- Fresenius Se & Co. KGaA
- Haemonetics Corporation
- Livanova PLC
- B. Braun Melsungen AG
Get Customization on this Report for Specific Research Solutions –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7783
Winning Strategy
Patient blood management providers are focusing on automation as demand for automated blood management is witnessing a huge rise and is projected to continue to do the same across the forecast period. Many companies are expected to focus on collaborations and partnerships to enhance their market presence and drive revenue generation capacity.
This patient blood management research survey by Fact.MR, a market research and competitive intelligence provider, discusses all the key strategies adopted by major and minor companies to enhance their sales and revenue potential. Haemonetics Corporation, Bio-Rad Laboratories Inc., Immucor Inc., B. Braun Melsungen AG, Fresenius Se & Co. KGaA, Macopharma, and Biomérieux SA are some of the prime companies profiled in this study.
Patient Blood Management Industry Research Segments
- By Product :
- Instruments
- Blood Processing Devices
- Centrifuges
- Blood Cell Processors
- Blood Transfusion Devices
- Apheresis Machines
- Plasma & Plasma Component Separators
- Cell Salvage Systems
- Others
- Blood Culture Screening Devices
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Diagnostic & Testing Instruments
- PCR Instruments
- Hematology Analyzers
- NGS Platforms
- Blood Grouping Analyzers
- Blood Storage Devices
- Medical Refrigerators
- Medical Freezers
- Blood Processing Devices
- Accessories
- Syringes & Needles
- Vials & Tubes
- Blood Bags
- Others
- Reagents & Kits
- Blood Culture Media
- Blood Typing Reagents
- Slide Staining Reagents
- Assay Kits
- Others
- Software
- Blood Bank Management Software
- Transfusion Management Software
- Others
- Instruments
- By Component :
- Whole Blood & Red Blood Cells
- Plasma
- By End User :
- Hospitals
- Diagnostic Clinics
- Blood Banks
- Pathology Labs
- By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Get Free Access To the Complete Report –
https://www.factmr.com/checkout/7783
Global Patient Blood Management Market Analysis and Forecast by Region
- North America Patient Blood Management Market Size and Forecast, 2022-2032
- Germany Patient Blood Management Market Size and Forecast, 2022-2032
- UK Patient Blood Management Market Size and Forecast, 2022-2032
- France Patient Blood Management Market Size and Forecast, 2022-2032
- Spain Patient Blood Management Market Size and Forecast, 2022-2032
- Japan Patient Blood Management Market Size and Forecast, 2022-2032
- China Patient Blood Management Market Size and Forecast, 2022-2032
- Malaysia Patient Blood Management Market Size and Forecast, 2022-2032
- Thailand Patient Blood Management Market Size and Forecast, 2022-2032
- Australia Patient Blood Management Market Size and Forecast, 2022-2032
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global patient blood management market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.
The study divulges essential insights on the market on the basis of product type (instruments, accessories, reagents & kits, software), component (plasma, whole blood & red blood cells), and end user (hospitals, diagnostic clinics, blood banks, pathology labs), across five major regions (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).
Check out more related studies published by Fact.MR Research:
Blood Testing Devices Market - Blood testing devices which would exceed industry standards are being developed, and manufactured by key industry leaders. Connected devices and the internet of things are new advances which are expected to drive the future market. Manufacturers are developing connected apps with personalized blood testing to bring new avenues to customers.
Blood Glucose Testing Devices Market - The growing adoption of blood glucose testing devices amongst a considerable diabetic patient pool is expected to fuel the growth of the global blood glucose testing devices market. The objective would be to conduct blood glucose testing as often and where ever an individual/patient likes, ensuring they avoid any sudden hypoglycemic events.
Blood Bank Analyzers Market - Rising awareness in developing and developed countries about the blood transfusion-related complications and disorders expected to drive the global blood bank analyzers market in the near future. With the growing influence of immunohematology market, Blood bank analyzers market expected to show the positive growth by accepting the new technologies in the future.
Medical Case Management Service Market - The global medical case management service market. The analysts have predicted the industry to expand at a stagnant CAGR of around 3.2% over the decade. The market valuation, which is expected to be US$ 4 Bn by the end of 2021 and is predicted to rise 1.3X by the end of decade.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
E: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
